An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein (Q89991428)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

title

An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

Stormy E Ruiz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

Pamela J. Bjorkman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

author name string

Jordan Salas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

Semi Rho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

Justin R Bailey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

publication date

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

Somatic Hypermutation Introduces Insertions and Deletions into Immunoglobulin V Genes

10 April 2020

cites work

1 reference

12 December 2020

Somatic insertions and deletions shape the human antibody repertoire

1 reference

12 December 2020

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

1 reference

12 December 2020

Neutralizing antibody response during acute and chronic hepatitis C virus infection

1 reference

12 December 2020

Coot: model-building tools for molecular graphics

1 reference

12 December 2020

Codon insertion and deletion functions as a somatic diversification mechanism in human antibody repertoires

1 reference

12 December 2020

Inference of macromolecular assemblies from crystalline state

1 reference

12 December 2020

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

1 reference

12 December 2020

Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus

1 reference

12 December 2020

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

1 reference

12 December 2020

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus

1 reference

12 December 2020

Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.

1 reference

12 December 2020

MolProbity: all-atom structure validation for macromolecular crystallography

1 reference

12 December 2020

PHENIX: a comprehensive Python-based system for macromolecular structure solution

1 reference

12 December 2020

An Insertion Mutation That Distorts Antibody Binding Site Architecture Enhances Function of a Human Antibody

1 reference

12 December 2020

iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM

1 reference

12 December 2020

Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome

1 reference

12 December 2020

How good are my data and what is the resolution?

1 reference

12 December 2020

Hepatitis C Virus E2 Envelope Glycoprotein Core Structure

1 reference

12 December 2020

Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses

1 reference

12 December 2020

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

1 reference

12 December 2020

Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies

1 reference

12 December 2020

Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance

1 reference

12 December 2020

Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.

1 reference

12 December 2020

abYsis: Integrated Antibody Sequence and Structure-Management, Analysis, and Prediction

1 reference

12 December 2020

Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets

1 reference

12 December 2020

Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.

1 reference

12 December 2020

HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design

1 reference

12 December 2020

Genetic and structural insights into broad neutralization of hepatitis C virus by human V1-69 antibodies

1 reference

12 December 2020

Breaking the law: unconventional strategies for antibody diversification

1 reference

12 December 2020

VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design

1 reference

12 December 2020

Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design

1 reference

12 December 2020

Identifiers

DOI

10.7554/ELIFE.53169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32125272 AND SRC:MED&resulttype=core&format=json

10 April 2020

PubMed publication ID

32125272

1 reference